Effect of oral melatonin on the procoagulant response to acute psychosocial stress in healthy men: A randomized placebo-controlled study

Journal of Pineal Research

Volumn 44, Issue 4, 2008, Pages 358-365

  Wirtz, Petra H ^a   Bärtschi, Carmen ^a   Spillmann, Maria ^a   Ehlert, Ulrike ^a   Von Känel, Roland ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cardiovascular disease; Coagulation; Hemostasis; Melatonin; Psychological stress

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; D DIMER; MELATONIN;

ADULT; ARTICLE; BLOOD CLOTTING; CATECHOLAMINE RELEASE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPERCOAGULABILITY; MALE; MENTAL STRESS; NORMAL HUMAN; SINGLE DRUG DOSE;

ACUTE CORONARY SYNDROME; ADMINISTRATION, ORAL; ADULT; ANTIGENS; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; FACTOR VII; FACTOR VIII; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MELATONIN; STRESS, PSYCHOLOGICAL; THROMBOPHILIA;

EID: 42149094558     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00535.x     Document Type: Article

References (53)

1. Bhattacharyya MR, Steptoe A. Emotional triggers of acute coronary syndromes: strength of evidence, biological processes, and clinical implications. Prog Cardiovasc Dis 2007 49 : 353 365.
2. Servoss SJ, Januzzi JL, Muller JE. Triggers of acute coronary syndromes. Prog Cardiovasc Dis 2002 44 : 369 380.
3. Krantz DS, Kop WJ, Santiago HT et al. Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin 1996 14 : 271 287.
4. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003 108 : 1772 1778.
5. Von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000 65 : 357 369.
6. Von Kanel R, Mills PJ, Ziegler MG et al. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002 144 : 68 72.
7. Wirtz PH, Ehlert U, Emini L et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med 2006 68 : 851 858.
8. Von Kanel R, Preckel D, Zgraggen L et al. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost 2004 92 : 1327 1335.
9. Colman RW, Clowes AW, George JN et al. Overview of Hemostasis. In : Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Lippincott Williams & Wilkins, Philadelphia, 2001 pp. 7 14.
10. Brzezinski A. Melatonin in humans. N Engl J Med 1997 336 : 186 195.
11. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005 9 : 11 24.
12. Sakotnik A, Liebmann PM, Stoschitzky K et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999 20 : 1314 1317.
13. Yaprak M, Altun A, Vardar A et al. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 2003 89 : 103 107.
14. Girotti L, Lago M, Ianovsky O et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res 2000 29 : 138 142.
15. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ et al. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002 33 : 248 252.
16. Lotufo CM, Lopes C, Dubocovich ML et al. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001 430 : 351 357.
17. Tunali T, Sener G, Yarat A et al. Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. Life Sci 2005 76 : 1259 1265.
18. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998 25 : 184 191.
19. Del Zar MM, Martinuzzo M, Falcon C et al. Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation. J Clin Endocrinol Metab 1990 70 : 246 251.
20. Kornblihtt LI, Finocchiaro L, Molinas FC. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid. J Pineal Res 1993 14 : 184 191.
21. Nishiyama K, Yasue H, Moriyama Y et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 2001 141 : E9.
22. Cagnacci A, Arangino S, Angiolucci M et al. Influences of melatonin administration on the circulation of women. Am J Physiol 1998 274 : R335 R338.
23. Arangino S, Cagnacci A, Angiolucci M et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999 83 : 1417 1419.
24. Lip GY, Li-Saw-Hee FL. Does hypertension confer a hypercoagulable state? J Hypertens 1998 16 : 913 916.
25. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol 2006 60 : 144 151.
26. Mertens I, Van Gaal LF. Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med 2005 5 : 48 55.
27. Von Kanel R, Nelesen RA, Ziegler MG et al. Relation of autonomic activity to plasminogen activator inhibitor-1 plasma concentration and the role of body mass index. Blood Coagul Fibrinolysis 2007 18 : 353 359.
28. Waldhauser F, Waldhauser M, Lieberman HR et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984 39 : 307 313.
29. Dollins AB, Zhdanova IV, Wurtman RJ et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A 1994 91 : 1824 1828.
30. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'- a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993 28 : 76 81.
31. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957 17 : 237 246.
32. Ehrenreich H, Schuck J, Stender N et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997 21 : 1285 1293.
33. Vieira R, Miguez J, Lema M et al. Pineal and plasma melatonin as determined by high-performance liquid chromatography with electrochemical detection. Anal Biochem 1992 205 : 300 305.
34. Hornung R, Reed L. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990 5 : 46 51.
35. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004 66 : 411 421.
36. Wirtz PH, Spillmann M, Bärtschi C et al. Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men. J Pineal Res. In press.
37. Lip GY, Lowe GD. Fibrin d-dimer: a useful clinical marker of thrombogenesis? Clin Sci (Lond) 1995 89 : 205 214.
38. Von Kanel R, Dimsdale JE. Fibrin d-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003 26 : 164 168.
39. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987 70 : 343 350.
40. Dawson D, Gibbon S, Singh P. The hypothermic effect of melatonin on core body temperature: is more better? J Pineal Res 1996 20 : 192 197.
41. Von Kanel R, Mills PJ, Fainman C et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001 63 : 531 544.
42. Yenari MA, Palmer JT, Bracci PM et al. Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res 1995 77 : 475 481.
43. Van der putten RF, Glatz JF, Hermens WT. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta 2006 371 : 37 54.
44. Fiotti N, Di Chiara A, Altamura N et al. Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. Blood Coagul Fibrinolysis 2002 13 : 247 255.
45. Thrall G, Lane D, Carroll D et al. A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007 120 : 819 847.
46. Rudnicka AR, Rumley A, Lowe GD et al. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin d-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007 115 : 996 1003.
47. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
48. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
49. Doolen S, Krause DN, Dubocovich ML et al. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 1998 345 : 67 69.
50. Monroe KK, Watts SW. The vascular reactivity of melatonin. Gen Pharmacol 1998 30 : 31 35.
51. Muller G, Goettsch C, Morawietz H. Oxidative stress and endothelial dysfunction. Hamostaseologie 2007 27 : 5 12.
52. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993 22 (Suppl 4 S1 S14.
53. Rosen J, Than NN, Koch D et al. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.